What is it about?
cMYC regulates approximately 15% of human genes and is involved in up to 20% of all human cancers. The aims of the current study were to clarify patterns and intensities of cMYC protein expression in follicular cell-derived thyroid carcinomas, to correlate cMYC with BRAFV600E expression, and to evaluate the potential role of cMYC in progression of well-differentiated thyroid carcinomas into less well-differentiated carcinomas.
Featured Image
Why is it important?
Our study suggests that nuclear overexpression of cMYC correlates with tumorigenesis / dedifferentiation in follicular cell derived thyroid carcinomas, a concept that has not been shown before on whole tissue sections.
Read the Original
This page is a summary of: cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis, Diagnostic Pathology, October 2017, Springer Science + Business Media,
DOI: 10.1186/s13000-017-0661-0.
You can read the full text:
Contributors
The following have contributed to this page







